source
- ARPA-H commits $62.7 million to develop FDA-authorized AI for heart-failure treatmentARPA-H announced a $62.7 million investment to create artificial-intelligence systems that can assist in treating heart failure. The program, called ADVOCATE, seeks to develop partially autonomous…
- Telemedicine firm begins offering GLP-1 medications to treat addictionA telemedicine company announced it will now prescribe GLP-1 class drugs to patients with substance-use disorders through its virtual platform. GLP-1 medications, originally approved for diabetes…